Last updated on July 2019

A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Brief description of study

The purpose of this study is to assess the safety and tolerability of pimavanserin compared to placebo in adult and elderly subjects with neuropsychiatric symptoms related to neurodegenerative disease.

Clinical Study Identifier: NCT03575052

Find a site near you

Start Over

Syrentis Clinical Research

Santa Ana, CA United States
  Connect »

Laszlo J Mate, MD, PA

North Palm Beach, FL United States
  Connect »

Bioclinica Research

The Villages, FL United States
  Connect »

Boston Center Memory

Newton, MA United States
  Connect »

The NeuroCognitive Institute

Mount Arlington, NJ United States
  Connect »

UNC Hospital

Chapel Hill, NC United States
  Connect »

Insight Clinical Trials LLC

Shaker Heights, OH United States
  Connect »

Axon Clinical

Praha 5, Czechia
  Connect »